Orpime 500mg Injection
Marketer
Orchid Chemicals & Pharmaceuticals Ltd
Salt Composition
Cefepime (500mg)
Overview Orpime 500mg Injection
Azithromycin 500mg Injection is a broad-spectrum antibiotic combating bacterial infections. It's indicated for severe bacterial infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, and bloodstream. Its mechanism involves bacterial cell death. Importantly, it's ineffective against viral infections. Azithromycin 500mg Injection is frequently administered to acutely ill hospitalized patients. Intravenous delivery, either by infusion or direct injection, is conducted under medical or nursing supervision. Dosage is tailored to the infection type, location, and severity. Continue treatment as directed, even with rapid symptom improvement; premature cessation may lead to relapse or exacerbation. Potential side effects include skin rash, pruritus, nausea, emesis, cephalgia, pyrexia, diarrhea, and local injection site erythema and edema. These are generally transient, resolving during therapy. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any pre-existing renal or hepatic impairment, or antibiotic allergies. Regular blood tests to monitor kidney function may be recommended. Generally considered safe during pregnancy and lactation under medical guidance.
Primary Ingredients of Orpime 500mg Injection
No text provided to rephrase.
Uses of Orpime 500mg Injection
Managing life-threatening bacterial infections
Major Benefits of Orpime 500mg Injection:
Administering this medication requires a healthcare professional; self-medication is strictly prohibited.
Common Side effects of Orpime 500mg Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
- Increased prothrombin time
- Decreased phosphate level in blood
- Increased partial thromboplastin time (PTT)
How to use Orpime 500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Orpime 500mg Injection works:
Orpime 500mg Injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, thereby preventing bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Orpime 500mg Injection can be used concomitantly with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Orpime, 500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Orpime 500mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no apparent threat to the infant. However, extended Orpime 500mg Injection use should be avoided due to potential side effects including skin rashes and loose stools.
DrivingCONSULT YOUR DOCTOR
Orpime 500mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, Orpime 500mg Injection requires careful administration. Dosage modification of Orpime 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Orpime 500mg Injection appears to be well-tolerated by individuals with hepatic impairment. Current evidence indicates dose modification of Orpime 500mg Injection may be unnecessary for this population; however, physician consultation is recommended.
What if you forget to take Orpime 500mg Injection :
Omit a dose of Orpime 500mg Injection? Seek your physician's advice.
Facts to Know About Orpime 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-spectrum cephalosporins (third and fourth generations) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Fourth-Generation Cephalosporins |
3,018 People bought this recently